Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
Mezigdomide Combinations Show Promise in Multiple Myeloma
4.
The risk of cancer is decreased by following international health recommendations.
5.
a cutting-edge cancer diagnostic tool.
1.
A Comprehensive Guide To Understanding Plasma Osmolality
2.
Case-Based Learning on Clonal Hematopoiesis With Unexpected Clinical Progression
3.
Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy
4.
Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production
5.
Case-Based Learning: Interpreting Unexpected Changes in Blood Counts During Longitudinal Clinical Follow-Up
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
2.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation